Call for Abstract

Scientific Program

World Congress and Exhibition on Antibiotics, will be organized around the theme “The Urgency of New Antibiotics and Control of Antibiotic Resistance”

Antibiotics-2015 is comprised of 35 tracks and 82 sessions designed to offer comprehensive sessions that address current issues in Antibiotics-2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 12:Antibiotics: Trauma and Surgical Infections

  • Track 12-1Control of resistant infections

Track 15:Drug Discovery and Novel Delivery Technologies

  • Track 15-1Policies to stimulate drug development and discovery

Track 16:The Emergence of Antimicrobial resistance

  • Track 16-1A public approach to antimicrobial resistance
  • Track 16-2Genetics of antimicrobial resistance
  • Track 16-3Proteomics of antimicrobial resistance
  • Track 16-4Antimicrobial resistance
  • Track 16-5Antimicrobial resistance in animal pathogens
  • Track 16-6Mechanism of Antimicrobial resistance
  • Track 16-7Alternate strategy to overcome the problem of antimicrobial resistance worldwide
  • Track 16-8Bacterial antibiotic resistance
  • Track 16-9Preventing drug resistance

Track 18:Antibiotic and antiviral drug resistance

  • Track 18-1HIV Antiviral Resistance

Track 19:Antibiotics and Child Care

  • Track 19-1 Antibiotics to Infants: Illness In Adulthood

Track 20:Antibiotics: Water Born Diseases

  • Track 20-1Protozoal infections
  • Track 20-2Parasitic infections
  • Track 20-3Bacterial infections
  • Track 20-4Viral infections
  • Track 20-5Algal Infections

Track 21:Antibiotics and Allergies: Clinical Update

  • Track 21-1Antibiotics and Dairy Allergies
  • Track 21-2Antibiotic Exposure in Infancy and Food Allergies
  • Track 21-3Management of Patients Reporting Antibiotic Hypersensitivity
  • Track 21-4Types and Diagnosis of Antibiotic Hypersensitivity

Track 22:Antibiotic Prophylaxis

  • Track 22-1Prevention of microbial infection
  • Track 22-2Antibiotic selection
  • Track 22-3Advantages of long-acting antibiotics

Track 24:Antibiotics: Food Industry

  • Track 24-1Antibiotics in Food Processing, Preservation and Supply
  • Track 24-2Antibiotics in Meat Industry
  • Track 24-3Antibiotic Resistance and Food Safety
  • Track 24-4Antibiotics: Food borne & Water borne Illnesses
  • Track 24-5Antibiotics in Nutrition
  • Track 24-6Nutrition and Probiotics
  • Track 24-7Antimicrobial resistance: Use of Antibiotics in Food

Track 25:Antibiotics: Agriculture

  • Track 25-1Plant Products as Antimicrobial Agents
  • Track 25-2Herbal Antibiotics & Ayurvedic Antibiotics
  • Track 25-3Antibiotics in livestock
  • Track 25-4Non-Judicious Uses of Antibiotics in Agriculture
  • Track 25-5Antimicrobial resistance: Use of Antibiotics in Agriculture

Track 26:Antibiotics: Veterinary

  • Track 26-1Antibiotics in Animal production
  • Track 26-2Antibiotic alternatives in animal production
  • Track 26-3Trends in antibiotic use per animal species and sectors

Track 27:Antibiotics in Aquaculture: Use, Abuse and Alternatives

  • Track 27-1Antibiotics in Shrimp Farming Track
  • Track 27-2Antibiotic resistance in aqua culture
  • Track 27-3Human health risks associated with the use of antibiotics in aquaculture
  • Track 27-4Approaches to minimizing antibiotics use in Aqua production
  • Track 27-5Disease resist strains in Aqua culture

Track 28:Antibiotics: In Pregnancy and Lactation

  • Track 28-1Safe Use of Anti‐infective Agents
  • Track 28-2Current Investigations in Broad Spectrum Antibiotics
  • Track 28-3Antibiotics and Neurological Damage

Track 32:Antibiotics in Dental and Oral care

  • Track 32-1Odontogenic infection

Track 33:Antibiotics in Prevention and Treatment of Inflammatory and Infectious Diseases

  • Track 33-1Sexually Transmitted Diseases: Gonorrhea, Chlamydia
  • Track 33-2Urinary tract infections: Prostate
  • Track 33-3Skin infections: Bacteria, Fungus, Virus, Algae, Insects
  • Track 33-4Respiratory tract infections: Bronchitis, Sinusitis, Cough, Throat, Pneumonia
  • Track 33-5Vaginal infections
  • Track 33-6Methicillin-resistant Staphylococcus aureus (MRSA)
  • Track 33-7Tuberculosis: Pulmonary TB, Extra pulmonary TB and Latent TB
  • Track 33-8Treatment for Drug Resistant TB
  • Track 33-9Antibiotics and Arthritis: Treatment Considerations

Track 34:The vast area of Antibiotics

  • Track 34-1Penicillins
  • Track 34-2Aminoglycosides
  • Track 34-3Ansamycins
  • Track 34-4Carbapenems
  • Track 34-5Cephalosporins (1,2, 3, 4, 5 generations)
  • Track 34-6Glycopeptides
  • Track 34-7Lincosamides
  • Track 34-8Lipopeptide
  • Track 34-9Macrolides
  • Track 34-10Monobactams
  • Track 34-11Nitrofurans
  • Track 34-12Oxazolidinones
  • Track 34-13Polypeptides
  • Track 34-14Quinolones
  • Track 34-15Sulfonamides
  • Track 34-16Tetracyclines

Track 35:Antibiotic Resistance: Opportunities and Challenges

  • Track 35-1Antibiotics and alternatives
  • Track 35-2Systemic Intervention – Values, Conflict and Blue Room Resolution
  • Track 35-3Novel Approaches to Diagnostics and Molecular Microbiology
  • Track 35-4Novel and Effective Surveillance and Epidemiology
  • Track 35-5Grand Challenges – Antimicrobial Resistance
  • Track 35-6Intervention against Antimicrobial Resistance – Approaches and Implementation